Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
World game at war: why some European nations have threatened a World Cup boycott 
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
MENLO PARK, Calif., April 17, 2018 -- Geron Corporation (Nasdaq:GERN) will hold its 2018 Annual Meeting of Stockholders, on Tuesday, May 15, 2018, at 4:00 p.m. PDT.
Geron’s stockholders are invited to attend the Annual Meeting in person at the company’s offices located at 149 Commonwealth Drive, Menlo Park, California 94025 or by conference call by dialing 877-303-9139 (U.S.) or 760-536-5195 (international). The conference ID is 7197767 or 68816558. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. Participants attending in person and by conference call will have an opportunity to ask questions during the meeting. In addition, stockholders may submit questions in advance of the meeting to the email address: [email protected]. A live audio-only webcast will also be available through the Investors section of Geron’s website at www.geron.com. The audio webcast of the Annual Meeting will be available for replay approximately one hour following the live broadcast through June 16, 2018.
First Quarter 2018 Financial Results Announcement Date
Geron will announce its financial results for the first quarter ended March 31, 2018 on Thursday, May 10, 2018, after the market close. Due to the proximity of the company’s Annual Meeting, Geron will not be hosting a separate first quarter conference call.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT:
Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
[email protected]
[email protected]
